Sabapathy, Suthakar, Cheryl Neslusan, Kim Yoong, Anna Teschemaker, Pierre Johansen, and Michael Willis. “COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA”. Journal of Population Therapeutics and Clinical Pharmacology 23, no. 2 (November 3, 2018). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/206.